nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylpropanolamine—ADRB2—asthma	0.171	1	CbGaD
Phenylpropanolamine—Levonordefrin—Isoetarine—asthma	0.105	0.409	CrCrCtD
Phenylpropanolamine—Levonordefrin—Isoprenaline—asthma	0.0797	0.31	CrCrCtD
Phenylpropanolamine—Levonordefrin—Salbutamol—asthma	0.0724	0.281	CrCrCtD
Phenylpropanolamine—ADRB2—Orciprenaline—asthma	0.0436	0.1	CbGbCtD
Phenylpropanolamine—ADRB2—Pirbuterol—asthma	0.0331	0.0758	CbGbCtD
Phenylpropanolamine—ADRB2—Terbutaline—asthma	0.0331	0.0758	CbGbCtD
Phenylpropanolamine—ADRB2—Isoetarine—asthma	0.0331	0.0758	CbGbCtD
Phenylpropanolamine—ADRB1—Isoetarine—asthma	0.0326	0.0747	CbGbCtD
Phenylpropanolamine—ADRB1—Pirbuterol—asthma	0.0326	0.0747	CbGbCtD
Phenylpropanolamine—ADRB2—Indacaterol—asthma	0.0229	0.0526	CbGbCtD
Phenylpropanolamine—ADRB1—Indacaterol—asthma	0.0226	0.0518	CbGbCtD
Phenylpropanolamine—ADRB2—Salmeterol—asthma	0.0213	0.0489	CbGbCtD
Phenylpropanolamine—ADRB2—Salbutamol—asthma	0.0213	0.0489	CbGbCtD
Phenylpropanolamine—ADRB1—Salbutamol—asthma	0.021	0.0481	CbGbCtD
Phenylpropanolamine—ADRB2—Isoprenaline—asthma	0.0181	0.0415	CbGbCtD
Phenylpropanolamine—ADRB1—Isoprenaline—asthma	0.0178	0.0409	CbGbCtD
Phenylpropanolamine—ADRB2—Formoterol—asthma	0.0161	0.037	CbGbCtD
Phenylpropanolamine—ADRB2—Arformoterol—asthma	0.0161	0.037	CbGbCtD
Phenylpropanolamine—ADRB1—Arformoterol—asthma	0.0159	0.0365	CbGbCtD
Phenylpropanolamine—ADRB1—Formoterol—asthma	0.0159	0.0365	CbGbCtD
Phenylpropanolamine—CYP1A2—Zileuton—asthma	0.00578	0.0133	CbGbCtD
Phenylpropanolamine—CYP1A2—Zafirlukast—asthma	0.00509	0.0117	CbGbCtD
Phenylpropanolamine—CYP1A2—Aminophylline—asthma	0.00418	0.00958	CbGbCtD
Phenylpropanolamine—CYP1A2—Theophylline—asthma	0.00393	0.00901	CbGbCtD
Phenylpropanolamine—SLC6A2—autonomic nervous system—asthma	0.00102	0.19	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—IL2—asthma	0.000473	0.339	CrCbGaD
Phenylpropanolamine—Benzyl alcohol—ALDH2—asthma	0.000435	0.312	CrCbGaD
Phenylpropanolamine—SLC6A3—respiratory system—asthma	0.000326	0.0607	CbGeAlD
Phenylpropanolamine—SLC6A2—respiratory system—asthma	0.000263	0.0489	CbGeAlD
Phenylpropanolamine—ADRB1—bronchus—asthma	0.000255	0.0474	CbGeAlD
Phenylpropanolamine—MAOA—respiratory system—asthma	0.000242	0.0451	CbGeAlD
Phenylpropanolamine—ADRB1—cardiovascular system—asthma	0.000237	0.0441	CbGeAlD
Phenylpropanolamine—ADRA1A—epithelium—asthma	0.000204	0.038	CbGeAlD
Phenylpropanolamine—MAOA—adrenal cortex—asthma	0.000203	0.0378	CbGeAlD
Phenylpropanolamine—CYP1A2—respiratory system—asthma	0.000202	0.0376	CbGeAlD
Phenylpropanolamine—MAOA—bronchus—asthma	0.000199	0.0371	CbGeAlD
Phenylpropanolamine—ADRA1A—cardiovascular system—asthma	0.000187	0.0348	CbGeAlD
Phenylpropanolamine—Ephedrine—ADRB2—asthma	0.000187	0.134	CrCbGaD
Phenylpropanolamine—MAOA—cardiovascular system—asthma	0.000186	0.0345	CbGeAlD
Phenylpropanolamine—MAOA—trachea—asthma	0.000179	0.0333	CbGeAlD
Phenylpropanolamine—SLC6A3—lung—asthma	0.000173	0.0322	CbGeAlD
Phenylpropanolamine—ADRB1—lung—asthma	0.000164	0.0306	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—TNF—asthma	0.00016	0.114	CrCbGaD
Phenylpropanolamine—SLC6A2—adrenal gland—asthma	0.000159	0.0296	CbGeAlD
Phenylpropanolamine—ADRA2A—bronchus—asthma	0.000153	0.0285	CbGeAlD
Phenylpropanolamine—ADRA1A—adrenal gland—asthma	0.000148	0.0276	CbGeAlD
Phenylpropanolamine—MAOA—adrenal gland—asthma	0.000147	0.0273	CbGeAlD
Phenylpropanolamine—Pseudoephedrine—ADRB2—asthma	0.000141	0.101	CrCbGaD
Phenylpropanolamine—SLC6A2—lung—asthma	0.00014	0.026	CbGeAlD
Phenylpropanolamine—ADRA2A—trachea—asthma	0.000137	0.0256	CbGeAlD
Phenylpropanolamine—Rash—Theophylline—asthma	0.000133	0.00165	CcSEcCtD
Phenylpropanolamine—Rash—Beclomethasone—asthma	0.000133	0.00165	CcSEcCtD
Phenylpropanolamine—Dermatitis—Theophylline—asthma	0.000132	0.00165	CcSEcCtD
Phenylpropanolamine—Dermatitis—Beclomethasone—asthma	0.000132	0.00165	CcSEcCtD
Phenylpropanolamine—Tension—Salbutamol—asthma	0.000132	0.00165	CcSEcCtD
Phenylpropanolamine—Agitation—Formoterol—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Agitation—Arformoterol—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Nausea—Zafirlukast—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Tremor—Montelukast—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Nervousness—Salbutamol—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Insomnia—Loratadine—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Tachycardia—Flunisolide—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—Insomnia—Tiotropium—asthma	0.000131	0.00163	CcSEcCtD
Phenylpropanolamine—MAOA—lung—asthma	0.000129	0.0239	CbGeAlD
Phenylpropanolamine—Somnolence—Loratadine—asthma	0.000129	0.0016	CcSEcCtD
Phenylpropanolamine—Agitation—Montelukast—asthma	0.000128	0.0016	CcSEcCtD
Phenylpropanolamine—Tension—Budesonide—asthma	0.000128	0.0016	CcSEcCtD
Phenylpropanolamine—Rash—Ciclesonide—asthma	0.000127	0.00158	CcSEcCtD
Phenylpropanolamine—Nervousness—Budesonide—asthma	0.000127	0.00158	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Dexamethasone—asthma	0.000127	0.00158	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Betamethasone—asthma	0.000127	0.00158	CcSEcCtD
Phenylpropanolamine—Dermatitis—Ciclesonide—asthma	0.000127	0.00158	CcSEcCtD
Phenylpropanolamine—Tremor—Salbutamol—asthma	0.000126	0.00157	CcSEcCtD
Phenylpropanolamine—Nausea—Theophylline—asthma	0.000125	0.00155	CcSEcCtD
Phenylpropanolamine—Nausea—Beclomethasone—asthma	0.000125	0.00155	CcSEcCtD
Phenylpropanolamine—Agitation—Salbutamol—asthma	0.000124	0.00154	CcSEcCtD
Phenylpropanolamine—Constipation—Loratadine—asthma	0.000124	0.00154	CcSEcCtD
Phenylpropanolamine—Constipation—Tiotropium—asthma	0.000123	0.00154	CcSEcCtD
Phenylpropanolamine—Vision blurred—Budesonide—asthma	0.000123	0.00153	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Ipratropium bromide—asthma	0.000123	0.00153	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Hydrocortisone—asthma	0.000122	0.00152	CcSEcCtD
Phenylpropanolamine—Tremor—Budesonide—asthma	0.000122	0.00152	CcSEcCtD
Phenylpropanolamine—Anxiety—Formoterol—asthma	0.000121	0.00151	CcSEcCtD
Phenylpropanolamine—Anxiety—Arformoterol—asthma	0.000121	0.00151	CcSEcCtD
Phenylpropanolamine—Insomnia—Flunisolide—asthma	0.000121	0.00151	CcSEcCtD
Phenylpropanolamine—Dizziness—Cromoglicic acid—asthma	0.000121	0.0015	CcSEcCtD
Phenylpropanolamine—Agitation—Budesonide—asthma	0.00012	0.00149	CcSEcCtD
Phenylpropanolamine—Irritability—Hydrocortisone—asthma	0.00012	0.00149	CcSEcCtD
Phenylpropanolamine—Nausea—Ciclesonide—asthma	0.000119	0.00149	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Flunisolide—asthma	0.000119	0.00149	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Loratadine—asthma	0.000119	0.00148	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Fluticasone Propionate—asthma	0.000119	0.00148	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Salmeterol—asthma	0.000119	0.00148	CcSEcCtD
Phenylpropanolamine—Anxiety—Montelukast—asthma	0.000119	0.00148	CcSEcCtD
Phenylpropanolamine—Rash—Cromoglicic acid—asthma	0.000115	0.00143	CcSEcCtD
Phenylpropanolamine—Dermatitis—Cromoglicic acid—asthma	0.000115	0.00143	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Methylprednisolone—asthma	0.000115	0.00143	CcSEcCtD
Phenylpropanolamine—Constipation—Flunisolide—asthma	0.000114	0.00142	CcSEcCtD
Phenylpropanolamine—Anxiety—Salbutamol—asthma	0.000114	0.00142	CcSEcCtD
Phenylpropanolamine—Tachycardia—Arformoterol—asthma	0.000114	0.00142	CcSEcCtD
Phenylpropanolamine—Tachycardia—Formoterol—asthma	0.000114	0.00142	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Aminophylline—asthma	0.000113	0.0014	CcSEcCtD
Phenylpropanolamine—ADRA2A—adrenal gland—asthma	0.000113	0.021	CbGeAlD
Phenylpropanolamine—Irritability—Methylprednisolone—asthma	0.000112	0.0014	CcSEcCtD
Phenylpropanolamine—Anxiety—Budesonide—asthma	0.000111	0.00138	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Mometasone—asthma	0.000111	0.00138	CcSEcCtD
Phenylpropanolamine—Euphoric mood—Prednisone—asthma	0.00011	0.00137	CcSEcCtD
Phenylpropanolamine—Dizziness—Ipratropium bromide—asthma	0.00011	0.00137	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Flunisolide—asthma	0.00011	0.00137	CcSEcCtD
Phenylpropanolamine—Hypotension—Arformoterol—asthma	0.000109	0.00136	CcSEcCtD
Phenylpropanolamine—Hypotension—Formoterol—asthma	0.000109	0.00136	CcSEcCtD
Phenylpropanolamine—Nausea—Cromoglicic acid—asthma	0.000109	0.00135	CcSEcCtD
Phenylpropanolamine—Confusional state—Budesonide—asthma	0.000107	0.00134	CcSEcCtD
Phenylpropanolamine—CYP1A2—lung—asthma	0.000107	0.02	CbGeAlD
Phenylpropanolamine—Tachycardia—Salbutamol—asthma	0.000107	0.00134	CcSEcCtD
Phenylpropanolamine—Dizziness—Fluticasone Propionate—asthma	0.000107	0.00133	CcSEcCtD
Phenylpropanolamine—Dizziness—Salmeterol—asthma	0.000107	0.00133	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Tiotropium—asthma	0.000106	0.00132	CcSEcCtD
Phenylpropanolamine—Vomiting—Ipratropium bromide—asthma	0.000106	0.00132	CcSEcCtD
Phenylpropanolamine—Insomnia—Formoterol—asthma	0.000105	0.00131	CcSEcCtD
Phenylpropanolamine—Insomnia—Arformoterol—asthma	0.000105	0.00131	CcSEcCtD
Phenylpropanolamine—Rash—Ipratropium bromide—asthma	0.000105	0.00131	CcSEcCtD
Phenylpropanolamine—Dermatitis—Ipratropium bromide—asthma	0.000105	0.00131	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Betamethasone—asthma	0.000105	0.0013	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Dexamethasone—asthma	0.000105	0.0013	CcSEcCtD
Phenylpropanolamine—Tachycardia—Budesonide—asthma	0.000104	0.00129	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Formoterol—asthma	0.000104	0.00129	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Arformoterol—asthma	0.000104	0.00129	CcSEcCtD
Phenylpropanolamine—Somnolence—Formoterol—asthma	0.000104	0.00129	CcSEcCtD
Phenylpropanolamine—Somnolence—Arformoterol—asthma	0.000104	0.00129	CcSEcCtD
Phenylpropanolamine—Insomnia—Montelukast—asthma	0.000103	0.00129	CcSEcCtD
Phenylpropanolamine—Hypotension—Salbutamol—asthma	0.000103	0.00128	CcSEcCtD
Phenylpropanolamine—Vomiting—Fluticasone Propionate—asthma	0.000103	0.00128	CcSEcCtD
Phenylpropanolamine—Vomiting—Salmeterol—asthma	0.000102	0.00128	CcSEcCtD
Phenylpropanolamine—Irritability—Dexamethasone—asthma	0.000102	0.00127	CcSEcCtD
Phenylpropanolamine—Irritability—Betamethasone—asthma	0.000102	0.00127	CcSEcCtD
Phenylpropanolamine—Rash—Fluticasone Propionate—asthma	0.000102	0.00127	CcSEcCtD
Phenylpropanolamine—Dermatitis—Fluticasone Propionate—asthma	0.000102	0.00127	CcSEcCtD
Phenylpropanolamine—Rash—Salmeterol—asthma	0.000102	0.00127	CcSEcCtD
Phenylpropanolamine—Dermatitis—Salmeterol—asthma	0.000102	0.00126	CcSEcCtD
Phenylpropanolamine—Somnolence—Montelukast—asthma	0.000101	0.00126	CcSEcCtD
Phenylpropanolamine—Dizziness—Aminophylline—asthma	0.000101	0.00126	CcSEcCtD
Phenylpropanolamine—Constipation—Formoterol—asthma	9.96e-05	0.00124	CcSEcCtD
Phenylpropanolamine—Constipation—Arformoterol—asthma	9.96e-05	0.00124	CcSEcCtD
Phenylpropanolamine—Insomnia—Salbutamol—asthma	9.95e-05	0.00124	CcSEcCtD
Phenylpropanolamine—Nausea—Ipratropium bromide—asthma	9.91e-05	0.00123	CcSEcCtD
Phenylpropanolamine—ADRA2A—lung—asthma	9.87e-05	0.0184	CbGeAlD
Phenylpropanolamine—Hypersensitivity—Flunisolide—asthma	9.86e-05	0.00123	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Salbutamol—asthma	9.81e-05	0.00122	CcSEcCtD
Phenylpropanolamine—Somnolence—Salbutamol—asthma	9.78e-05	0.00122	CcSEcCtD
Phenylpropanolamine—Vomiting—Aminophylline—asthma	9.73e-05	0.00121	CcSEcCtD
Phenylpropanolamine—Rash—Aminophylline—asthma	9.65e-05	0.0012	CcSEcCtD
Phenylpropanolamine—Dermatitis—Aminophylline—asthma	9.64e-05	0.0012	CcSEcCtD
Phenylpropanolamine—Insomnia—Budesonide—asthma	9.64e-05	0.0012	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Formoterol—asthma	9.6e-05	0.0012	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Arformoterol—asthma	9.6e-05	0.0012	CcSEcCtD
Phenylpropanolamine—Nausea—Fluticasone Propionate—asthma	9.6e-05	0.00119	CcSEcCtD
Phenylpropanolamine—Nausea—Salmeterol—asthma	9.57e-05	0.00119	CcSEcCtD
Phenylpropanolamine—Dizziness—Loratadine—asthma	9.56e-05	0.00119	CcSEcCtD
Phenylpropanolamine—Dizziness—Tiotropium—asthma	9.55e-05	0.00119	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Budesonide—asthma	9.5e-05	0.00118	CcSEcCtD
Phenylpropanolamine—Somnolence—Budesonide—asthma	9.47e-05	0.00118	CcSEcCtD
Phenylpropanolamine—Constipation—Salbutamol—asthma	9.41e-05	0.00117	CcSEcCtD
Phenylpropanolamine—Vomiting—Loratadine—asthma	9.19e-05	0.00114	CcSEcCtD
Phenylpropanolamine—Vomiting—Tiotropium—asthma	9.18e-05	0.00114	CcSEcCtD
Phenylpropanolamine—Rash—Loratadine—asthma	9.12e-05	0.00114	CcSEcCtD
Phenylpropanolamine—Constipation—Budesonide—asthma	9.11e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Psychotic disorder—Prednisone—asthma	9.11e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Dermatitis—Loratadine—asthma	9.11e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Rash—Tiotropium—asthma	9.1e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Dermatitis—Tiotropium—asthma	9.09e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Nausea—Aminophylline—asthma	9.09e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Salbutamol—asthma	9.06e-05	0.00113	CcSEcCtD
Phenylpropanolamine—Irritability—Prednisone—asthma	8.9e-05	0.00111	CcSEcCtD
Phenylpropanolamine—Dizziness—Flunisolide—asthma	8.85e-05	0.0011	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Budesonide—asthma	8.78e-05	0.00109	CcSEcCtD
Phenylpropanolamine—Hallucination—Hydrocortisone—asthma	8.63e-05	0.00107	CcSEcCtD
Phenylpropanolamine—Nausea—Loratadine—asthma	8.59e-05	0.00107	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Formoterol—asthma	8.58e-05	0.00107	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Arformoterol—asthma	8.58e-05	0.00107	CcSEcCtD
Phenylpropanolamine—Nausea—Tiotropium—asthma	8.57e-05	0.00107	CcSEcCtD
Phenylpropanolamine—Vomiting—Flunisolide—asthma	8.51e-05	0.00106	CcSEcCtD
Phenylpropanolamine—Rash—Flunisolide—asthma	8.44e-05	0.00105	CcSEcCtD
Phenylpropanolamine—Dermatitis—Flunisolide—asthma	8.43e-05	0.00105	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Montelukast—asthma	8.41e-05	0.00105	CcSEcCtD
Phenylpropanolamine—Hallucination—Methylprednisolone—asthma	8.11e-05	0.00101	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Salbutamol—asthma	8.1e-05	0.00101	CcSEcCtD
Phenylpropanolamine—Nausea—Flunisolide—asthma	7.95e-05	0.00099	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisolone—asthma	7.93e-05	0.000988	CcSEcCtD
Phenylpropanolamine—Vomiting—Mometasone—asthma	7.89e-05	0.000983	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Budesonide—asthma	7.85e-05	0.000977	CcSEcCtD
Phenylpropanolamine—Rash—Mometasone—asthma	7.82e-05	0.000974	CcSEcCtD
Phenylpropanolamine—Dermatitis—Mometasone—asthma	7.82e-05	0.000973	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Hydrocortisone—asthma	7.75e-05	0.000965	CcSEcCtD
Phenylpropanolamine—Dizziness—Arformoterol—asthma	7.7e-05	0.000959	CcSEcCtD
Phenylpropanolamine—Dizziness—Formoterol—asthma	7.7e-05	0.000959	CcSEcCtD
Phenylpropanolamine—Dizziness—Montelukast—asthma	7.55e-05	0.00094	CcSEcCtD
Phenylpropanolamine—Vomiting—Arformoterol—asthma	7.41e-05	0.000922	CcSEcCtD
Phenylpropanolamine—Vomiting—Formoterol—asthma	7.41e-05	0.000922	CcSEcCtD
Phenylpropanolamine—Hallucination—Betamethasone—asthma	7.37e-05	0.000918	CcSEcCtD
Phenylpropanolamine—Hallucination—Dexamethasone—asthma	7.37e-05	0.000918	CcSEcCtD
Phenylpropanolamine—Nausea—Mometasone—asthma	7.37e-05	0.000918	CcSEcCtD
Phenylpropanolamine—Rash—Formoterol—asthma	7.35e-05	0.000915	CcSEcCtD
Phenylpropanolamine—Rash—Arformoterol—asthma	7.35e-05	0.000915	CcSEcCtD
Phenylpropanolamine—Dermatitis—Formoterol—asthma	7.34e-05	0.000914	CcSEcCtD
Phenylpropanolamine—Dermatitis—Arformoterol—asthma	7.34e-05	0.000914	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Triamcinolone—asthma	7.3e-05	0.000908	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisolone—asthma	7.29e-05	0.000907	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Methylprednisolone—asthma	7.28e-05	0.000906	CcSEcCtD
Phenylpropanolamine—Dizziness—Salbutamol—asthma	7.27e-05	0.000906	CcSEcCtD
Phenylpropanolamine—Vomiting—Montelukast—asthma	7.25e-05	0.000903	CcSEcCtD
Phenylpropanolamine—Rash—Montelukast—asthma	7.19e-05	0.000896	CcSEcCtD
Phenylpropanolamine—Dermatitis—Montelukast—asthma	7.19e-05	0.000895	CcSEcCtD
Phenylpropanolamine—Dizziness—Budesonide—asthma	7.05e-05	0.000877	CcSEcCtD
Phenylpropanolamine—Vomiting—Salbutamol—asthma	6.99e-05	0.000871	CcSEcCtD
Phenylpropanolamine—Rash—Salbutamol—asthma	6.94e-05	0.000864	CcSEcCtD
Phenylpropanolamine—Dermatitis—Salbutamol—asthma	6.93e-05	0.000863	CcSEcCtD
Phenylpropanolamine—Nausea—Formoterol—asthma	6.92e-05	0.000862	CcSEcCtD
Phenylpropanolamine—Nausea—Arformoterol—asthma	6.92e-05	0.000862	CcSEcCtD
Phenylpropanolamine—Nausea—Montelukast—asthma	6.78e-05	0.000844	CcSEcCtD
Phenylpropanolamine—Vomiting—Budesonide—asthma	6.77e-05	0.000844	CcSEcCtD
Phenylpropanolamine—Rash—Budesonide—asthma	6.72e-05	0.000837	CcSEcCtD
Phenylpropanolamine—Dermatitis—Budesonide—asthma	6.71e-05	0.000836	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Betamethasone—asthma	6.62e-05	0.000824	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Dexamethasone—asthma	6.62e-05	0.000824	CcSEcCtD
Phenylpropanolamine—Nausea—Salbutamol—asthma	6.53e-05	0.000814	CcSEcCtD
Phenylpropanolamine—Hallucination—Prednisone—asthma	6.42e-05	0.000799	CcSEcCtD
Phenylpropanolamine—Anxiety—Hydrocortisone—asthma	6.41e-05	0.000798	CcSEcCtD
Phenylpropanolamine—Nausea—Budesonide—asthma	6.33e-05	0.000788	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisolone—asthma	6.16e-05	0.000767	CcSEcCtD
Phenylpropanolamine—Anxiety—Methylprednisolone—asthma	6.02e-05	0.000749	CcSEcCtD
Phenylpropanolamine—Tachycardia—Hydrocortisone—asthma	6.01e-05	0.000749	CcSEcCtD
Phenylpropanolamine—Flushing—Prednisone—asthma	5.99e-05	0.000746	CcSEcCtD
Phenylpropanolamine—Confusional state—Methylprednisolone—asthma	5.84e-05	0.000727	CcSEcCtD
Phenylpropanolamine—Arrhythmia—Prednisone—asthma	5.76e-05	0.000718	CcSEcCtD
Phenylpropanolamine—Hypotension—Hydrocortisone—asthma	5.76e-05	0.000717	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisolone—asthma	5.71e-05	0.000711	CcSEcCtD
Phenylpropanolamine—Tachycardia—Triamcinolone—asthma	5.66e-05	0.000705	CcSEcCtD
Phenylpropanolamine—Tachycardia—Methylprednisolone—asthma	5.65e-05	0.000704	CcSEcCtD
Phenylpropanolamine—Insomnia—Hydrocortisone—asthma	5.57e-05	0.000694	CcSEcCtD
Phenylpropanolamine—Anxiety—Dexamethasone—asthma	5.47e-05	0.000681	CcSEcCtD
Phenylpropanolamine—Anxiety—Betamethasone—asthma	5.47e-05	0.000681	CcSEcCtD
Phenylpropanolamine—Hypotension—Methylprednisolone—asthma	5.41e-05	0.000674	CcSEcCtD
Phenylpropanolamine—Vision blurred—Prednisone—asthma	5.29e-05	0.000659	CcSEcCtD
Phenylpropanolamine—Insomnia—Triamcinolone—asthma	5.25e-05	0.000653	CcSEcCtD
Phenylpropanolamine—Insomnia—Methylprednisolone—asthma	5.24e-05	0.000652	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisolone—asthma	5.2e-05	0.000647	CcSEcCtD
Phenylpropanolamine—Dyspnoea—Triamcinolone—asthma	5.17e-05	0.000644	CcSEcCtD
Phenylpropanolamine—Agitation—Prednisone—asthma	5.16e-05	0.000643	CcSEcCtD
Phenylpropanolamine—Tachycardia—Dexamethasone—asthma	5.14e-05	0.00064	CcSEcCtD
Phenylpropanolamine—Tachycardia—Betamethasone—asthma	5.14e-05	0.00064	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Hydrocortisone—asthma	5.08e-05	0.000632	CcSEcCtD
Phenylpropanolamine—Hypotension—Dexamethasone—asthma	4.92e-05	0.000613	CcSEcCtD
Phenylpropanolamine—Hypotension—Betamethasone—asthma	4.92e-05	0.000613	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Triamcinolone—asthma	4.78e-05	0.000595	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Methylprednisolone—asthma	4.77e-05	0.000594	CcSEcCtD
Phenylpropanolamine—Anxiety—Prednisone—asthma	4.77e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Insomnia—Dexamethasone—asthma	4.76e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Insomnia—Betamethasone—asthma	4.76e-05	0.000593	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisolone—asthma	4.65e-05	0.000579	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Hydrocortisone—asthma	4.54e-05	0.000565	CcSEcCtD
Phenylpropanolamine—Tachycardia—Prednisone—asthma	4.47e-05	0.000557	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Dexamethasone—asthma	4.34e-05	0.00054	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Betamethasone—asthma	4.34e-05	0.00054	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Triamcinolone—asthma	4.27e-05	0.000532	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Methylprednisolone—asthma	4.26e-05	0.000531	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisolone—asthma	4.17e-05	0.00052	CcSEcCtD
Phenylpropanolamine—Insomnia—Prednisone—asthma	4.15e-05	0.000516	CcSEcCtD
Phenylpropanolamine—Dizziness—Hydrocortisone—asthma	4.07e-05	0.000507	CcSEcCtD
Phenylpropanolamine—Rash—Prednisolone—asthma	3.98e-05	0.000495	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisolone—asthma	3.97e-05	0.000495	CcSEcCtD
Phenylpropanolamine—Constipation—Prednisone—asthma	3.92e-05	0.000488	CcSEcCtD
Phenylpropanolamine—Vomiting—Hydrocortisone—asthma	3.92e-05	0.000488	CcSEcCtD
Phenylpropanolamine—Rash—Hydrocortisone—asthma	3.88e-05	0.000484	CcSEcCtD
Phenylpropanolamine—Dermatitis—Hydrocortisone—asthma	3.88e-05	0.000483	CcSEcCtD
Phenylpropanolamine—Dizziness—Triamcinolone—asthma	3.84e-05	0.000478	CcSEcCtD
Phenylpropanolamine—Dizziness—Methylprednisolone—asthma	3.83e-05	0.000477	CcSEcCtD
Phenylpropanolamine—Feeling abnormal—Prednisone—asthma	3.78e-05	0.00047	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisolone—asthma	3.75e-05	0.000467	CcSEcCtD
Phenylpropanolamine—Vomiting—Triamcinolone—asthma	3.69e-05	0.000459	CcSEcCtD
Phenylpropanolamine—Vomiting—Methylprednisolone—asthma	3.68e-05	0.000458	CcSEcCtD
Phenylpropanolamine—Nausea—Hydrocortisone—asthma	3.66e-05	0.000456	CcSEcCtD
Phenylpropanolamine—Rash—Triamcinolone—asthma	3.66e-05	0.000456	CcSEcCtD
Phenylpropanolamine—Dermatitis—Triamcinolone—asthma	3.65e-05	0.000455	CcSEcCtD
Phenylpropanolamine—Rash—Methylprednisolone—asthma	3.65e-05	0.000455	CcSEcCtD
Phenylpropanolamine—Dermatitis—Methylprednisolone—asthma	3.65e-05	0.000454	CcSEcCtD
Phenylpropanolamine—Dizziness—Dexamethasone—asthma	3.48e-05	0.000433	CcSEcCtD
Phenylpropanolamine—Dizziness—Betamethasone—asthma	3.48e-05	0.000433	CcSEcCtD
Phenylpropanolamine—Nausea—Triamcinolone—asthma	3.45e-05	0.000429	CcSEcCtD
Phenylpropanolamine—Nausea—Methylprednisolone—asthma	3.44e-05	0.000428	CcSEcCtD
Phenylpropanolamine—Hypersensitivity—Prednisone—asthma	3.38e-05	0.000421	CcSEcCtD
Phenylpropanolamine—Vomiting—Betamethasone—asthma	3.35e-05	0.000417	CcSEcCtD
Phenylpropanolamine—Vomiting—Dexamethasone—asthma	3.35e-05	0.000417	CcSEcCtD
Phenylpropanolamine—Rash—Dexamethasone—asthma	3.32e-05	0.000413	CcSEcCtD
Phenylpropanolamine—Rash—Betamethasone—asthma	3.32e-05	0.000413	CcSEcCtD
Phenylpropanolamine—Dermatitis—Betamethasone—asthma	3.32e-05	0.000413	CcSEcCtD
Phenylpropanolamine—Dermatitis—Dexamethasone—asthma	3.32e-05	0.000413	CcSEcCtD
Phenylpropanolamine—Nausea—Dexamethasone—asthma	3.13e-05	0.000389	CcSEcCtD
Phenylpropanolamine—Nausea—Betamethasone—asthma	3.13e-05	0.000389	CcSEcCtD
Phenylpropanolamine—Dizziness—Prednisone—asthma	3.03e-05	0.000378	CcSEcCtD
Phenylpropanolamine—Vomiting—Prednisone—asthma	2.91e-05	0.000363	CcSEcCtD
Phenylpropanolamine—Rash—Prednisone—asthma	2.89e-05	0.00036	CcSEcCtD
Phenylpropanolamine—Dermatitis—Prednisone—asthma	2.89e-05	0.00036	CcSEcCtD
Phenylpropanolamine—Nausea—Prednisone—asthma	2.72e-05	0.000339	CcSEcCtD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NPS—asthma	4.92e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TAC1—asthma	4.92e-06	0.000101	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CSF2—asthma	4.9e-06	0.0001	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCR3—asthma	4.83e-06	9.87e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—GPCR downstream signaling—IL2—asthma	4.82e-06	9.86e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—ITPR1—asthma	4.77e-06	9.75e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SMAD3—asthma	4.77e-06	9.75e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—BDKRB2—asthma	4.75e-06	9.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—POMC—asthma	4.75e-06	9.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—RHOA—asthma	4.69e-06	9.6e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALOX5AP—asthma	4.69e-06	9.59e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALOX15—asthma	4.69e-06	9.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CYBA—asthma	4.68e-06	9.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—ITPR1—asthma	4.66e-06	9.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADCY2—asthma	4.6e-06	9.41e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—RHOA—asthma	4.59e-06	9.39e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—CXCL8—asthma	4.58e-06	9.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL3—asthma	4.58e-06	9.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PARP1—asthma	4.58e-06	9.36e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL5—asthma	4.58e-06	9.36e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PPP2CA—asthma	4.56e-06	9.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CD86—asthma	4.54e-06	9.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—CXCL8—asthma	4.54e-06	9.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EDN1—asthma	4.5e-06	9.21e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCR5—asthma	4.48e-06	9.16e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CHAT—asthma	4.47e-06	9.15e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL5—asthma	4.47e-06	9.14e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PLA2G4A—asthma	4.45e-06	9.1e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CD86—asthma	4.44e-06	9.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—CXCL8—asthma	4.44e-06	9.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—BDKRB2—asthma	4.42e-06	9.03e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2RA—asthma	4.41e-06	9.03e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—POMC—asthma	4.41e-06	9.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EDN1—asthma	4.41e-06	9.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CSF2—asthma	4.4e-06	9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—VEGFA—asthma	4.38e-06	8.97e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL2—asthma	4.38e-06	8.96e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—C3—asthma	4.38e-06	8.95e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL5—asthma	4.37e-06	8.94e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GSTP1—asthma	4.36e-06	8.91e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PLA2G4A—asthma	4.35e-06	8.91e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—GPCR downstream signaling—IL2—asthma	4.34e-06	8.87e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—KNG1—asthma	4.32e-06	8.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—POMC—asthma	4.31e-06	8.81e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CSF2—asthma	4.31e-06	8.81e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—AGTR1—asthma	4.3e-06	8.79e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—HMOX1—asthma	4.3e-06	8.78e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ITPR1—asthma	4.29e-06	8.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SMAD3—asthma	4.28e-06	8.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADCY2—asthma	4.27e-06	8.74e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PDGFB—asthma	4.26e-06	8.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL3—asthma	4.26e-06	8.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—GPCR downstream signaling—IL2—asthma	4.24e-06	8.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—CAT—asthma	4.24e-06	8.67e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—POMC—asthma	4.23e-06	8.66e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CCL2—asthma	4.22e-06	8.62e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6R—asthma	4.2e-06	8.6e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL10—asthma	4.2e-06	8.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SMAD3—asthma	4.19e-06	8.57e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—RHOA—asthma	4.18e-06	8.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NTRK1—asthma	4.12e-06	8.43e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—CXCL8—asthma	4.12e-06	8.43e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PPP2CA—asthma	4.1e-06	8.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ADRB2—asthma	4.08e-06	8.34e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—LEP—asthma	4.07e-06	8.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—CXCL8—asthma	4.03e-06	8.24e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCR5—asthma	4.03e-06	8.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Hemostasis—TGFB1—asthma	4.02e-06	8.23e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—KNG1—asthma	4.02e-06	8.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PPP2CA—asthma	4.01e-06	8.2e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—POMC—asthma	4e-06	8.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—GSTM1—asthma	4e-06	8.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PLA2G4A—asthma	4e-06	8.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—AGTR1—asthma	3.99e-06	8.17e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALOX5—asthma	3.99e-06	8.15e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2RA—asthma	3.97e-06	8.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCR5—asthma	3.94e-06	8.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL2—asthma	3.94e-06	8.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—C3—asthma	3.93e-06	8.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CCL2—asthma	3.92e-06	8.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6R—asthma	3.91e-06	7.99e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL10—asthma	3.9e-06	7.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—RHOA—asthma	3.89e-06	7.95e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2RA—asthma	3.88e-06	7.94e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—ALB—asthma	3.86e-06	7.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—ITPR1—asthma	3.86e-06	7.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL2—asthma	3.85e-06	7.88e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—C3—asthma	3.85e-06	7.87e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—FN1—asthma	3.84e-06	7.86e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PDGFB—asthma	3.83e-06	7.83e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NTRK1—asthma	3.83e-06	7.83e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CARM1—asthma	3.8e-06	7.78e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—RHOA—asthma	3.8e-06	7.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ADRB2—asthma	3.79e-06	7.75e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—DCN—asthma	3.75e-06	7.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PDGFB—asthma	3.75e-06	7.66e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—NOS3—asthma	3.69e-06	7.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PPP2CA—asthma	3.69e-06	7.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CD86—asthma	3.67e-06	7.51e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—CXCL8—asthma	3.67e-06	7.51e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—LEP—asthma	3.66e-06	7.49e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALDH2—asthma	3.65e-06	7.46e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EDN1—asthma	3.64e-06	7.45e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL5—asthma	3.62e-06	7.39e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PLA2G4A—asthma	3.6e-06	7.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—ITPR1—asthma	3.58e-06	7.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—LEP—asthma	3.58e-06	7.33e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CSF2—asthma	3.56e-06	7.28e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—RHOA—asthma	3.53e-06	7.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—GPCR downstream signaling—IL2—asthma	3.51e-06	7.18e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	3.51e-06	7.17e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—POMC—asthma	3.5e-06	7.16e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTT1—asthma	3.47e-06	7.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SMAD3—asthma	3.47e-06	7.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—FN1—asthma	3.45e-06	7.06e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CCL2—asthma	3.42e-06	7e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6R—asthma	3.41e-06	6.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CD86—asthma	3.41e-06	6.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—CXCL8—asthma	3.41e-06	6.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EDN1—asthma	3.39e-06	6.92e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—FN1—asthma	3.38e-06	6.91e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTGS2—asthma	3.38e-06	6.91e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL5—asthma	3.36e-06	6.87e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—EGFR—asthma	3.35e-06	6.85e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PLA2G4A—asthma	3.35e-06	6.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—CXCL8—asthma	3.33e-06	6.82e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PPP2CA—asthma	3.32e-06	6.78e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CSF2—asthma	3.31e-06	6.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—GPCR downstream signaling—IL2—asthma	3.26e-06	6.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCR5—asthma	3.26e-06	6.66e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SMAD3—asthma	3.22e-06	6.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2RA—asthma	3.21e-06	6.57e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—SERPINE1—asthma	3.2e-06	6.54e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	3.2e-06	6.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL2—asthma	3.19e-06	6.52e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—C3—asthma	3.18e-06	6.51e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—POMC—asthma	3.15e-06	6.43e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PDGFB—asthma	3.1e-06	6.34e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—CXCL8—asthma	3.1e-06	6.33e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—RHOA—asthma	3.08e-06	6.31e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PPP2CA—asthma	3.08e-06	6.3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CCL2—asthma	3.08e-06	6.3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—POMC—asthma	3.08e-06	6.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6R—asthma	3.07e-06	6.28e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—NOS3—asthma	3.05e-06	6.24e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCR5—asthma	3.03e-06	6.19e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—EGFR—asthma	3.01e-06	6.16e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CCL2—asthma	3.01e-06	6.16e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6R—asthma	3e-06	6.14e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2RA—asthma	2.98e-06	6.1e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—LEP—asthma	2.96e-06	6.06e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL2—asthma	2.96e-06	6.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—C3—asthma	2.96e-06	6.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—EGFR—asthma	2.95e-06	6.02e-05	CbGpPWpGaD
Phenylpropanolamine—MAOA—Metabolism—PTEN—asthma	2.95e-06	6.02e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NQO1—asthma	2.88e-06	5.9e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PDGFB—asthma	2.88e-06	5.89e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—SERPINE1—asthma	2.87e-06	5.88e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—POMC—asthma	2.83e-06	5.79e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ADCY2—asthma	2.82e-06	5.77e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—SERPINE1—asthma	2.81e-06	5.75e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.8e-06	5.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—FN1—asthma	2.79e-06	5.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—RHOA—asthma	2.77e-06	5.67e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—LEP—asthma	2.75e-06	5.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—NOS3—asthma	2.74e-06	5.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—RHOA—asthma	2.71e-06	5.55e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—CXCL8—asthma	2.71e-06	5.54e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—NOS3—asthma	2.68e-06	5.49e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—FN1—asthma	2.6e-06	5.31e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL2—asthma	2.59e-06	5.29e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—ALB—asthma	2.58e-06	5.27e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling by GPCR—IL6—asthma	2.57e-06	5.27e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—POMC—asthma	2.55e-06	5.21e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CCL2—asthma	2.49e-06	5.09e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6R—asthma	2.48e-06	5.08e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—NOS3—asthma	2.47e-06	5.05e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—MMP9—asthma	2.45e-06	5.01e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	2.44e-06	4.99e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—EGFR—asthma	2.44e-06	4.98e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—PTEN—asthma	2.43e-06	4.98e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—CXCL8—asthma	2.43e-06	4.98e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTP1—asthma	2.4e-06	4.92e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—CXCL8—asthma	2.38e-06	4.87e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—HMOX1—asthma	2.37e-06	4.85e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ITPR1—asthma	2.37e-06	4.84e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—POMC—asthma	2.37e-06	4.84e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—CAT—asthma	2.34e-06	4.78e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL2—asthma	2.33e-06	4.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—SERPINE1—asthma	2.33e-06	4.76e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling by GPCR—IL6—asthma	2.31e-06	4.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CCL2—asthma	2.31e-06	4.73e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6R—asthma	2.31e-06	4.72e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL2—asthma	2.28e-06	4.65e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling by GPCR—IL6—asthma	2.26e-06	4.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—EGFR—asthma	2.26e-06	4.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTGS2—asthma	2.26e-06	4.61e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—RHOA—asthma	2.24e-06	4.59e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—NOS3—asthma	2.22e-06	4.54e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PLA2G4A—asthma	2.21e-06	4.52e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—GSTM1—asthma	2.21e-06	4.52e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—MMP9—asthma	2.2e-06	4.5e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—VEGFA—asthma	2.2e-06	4.5e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—PTEN—asthma	2.19e-06	4.48e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—STAT3—asthma	2.18e-06	4.45e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—SERPINE1—asthma	2.16e-06	4.42e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—MMP9—asthma	2.15e-06	4.4e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—PTEN—asthma	2.14e-06	4.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—RHOA—asthma	2.08e-06	4.26e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—NOS3—asthma	2.06e-06	4.22e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PPP2CA—asthma	2.03e-06	4.16e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—TGFB1—asthma	2.02e-06	4.13e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—EGFR—asthma	1.98e-06	4.05e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—VEGFA—asthma	1.98e-06	4.04e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—CXCL8—asthma	1.97e-06	4.03e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Metabolism—PTEN—asthma	1.97e-06	4.02e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—STAT3—asthma	1.96e-06	4e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—VEGFA—asthma	1.93e-06	3.95e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—STAT3—asthma	1.91e-06	3.92e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL2—asthma	1.88e-06	3.85e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling by GPCR—IL6—asthma	1.87e-06	3.83e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—CXCL8—asthma	1.83e-06	3.74e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—TGFB1—asthma	1.81e-06	3.71e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—MMP9—asthma	1.78e-06	3.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—EGFR—asthma	1.78e-06	3.64e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—TGFB1—asthma	1.77e-06	3.63e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—PTEN—asthma	1.77e-06	3.62e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL2—asthma	1.75e-06	3.58e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—EGFR—asthma	1.74e-06	3.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling by GPCR—IL6—asthma	1.74e-06	3.56e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—MMP9—asthma	1.65e-06	3.38e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—PTEN—asthma	1.65e-06	3.37e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—VEGFA—asthma	1.6e-06	3.27e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—STAT3—asthma	1.58e-06	3.24e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—POMC—asthma	1.56e-06	3.19e-05	CbGpPWpGaD
Phenylpropanolamine—DRD1—Signaling Pathways—IL6—asthma	1.52e-06	3.11e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—VEGFA—asthma	1.49e-06	3.04e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—STAT3—asthma	1.47e-06	3.01e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—TGFB1—asthma	1.47e-06	3e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—EGFR—asthma	1.44e-06	2.94e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—ALB—asthma	1.42e-06	2.91e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB1—Signaling Pathways—IL6—asthma	1.37e-06	2.8e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—TGFB1—asthma	1.36e-06	2.79e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—NOS3—asthma	1.36e-06	2.79e-05	CbGpPWpGaD
Phenylpropanolamine—ADRB2—Signaling Pathways—IL6—asthma	1.34e-06	2.74e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—EGFR—asthma	1.34e-06	2.74e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTGS2—asthma	1.25e-06	2.55e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA1A—Signaling Pathways—IL6—asthma	1.11e-06	2.26e-05	CbGpPWpGaD
Phenylpropanolamine—CYP1A2—Metabolism—PTEN—asthma	1.09e-06	2.22e-05	CbGpPWpGaD
Phenylpropanolamine—ADRA2A—Signaling Pathways—IL6—asthma	1.03e-06	2.1e-05	CbGpPWpGaD
